PHOENIX, AZ--(Marketwired - March 30, 2016) - Now, for the first time, Canadians will have access to Cyrex Laboratories' advanced clinical tests for better understand health triggers and gauge immune function and autoimmune reactivity. Cyrex Laboratories' move into Canada is a direct result of healthcare professionals reporting the vast spread of multifaceted, chronic illnesses causing autoimmune diseases that can be triggered by food reactivity, lifestyle choices, and an increasingly toxic environment. Cyrex was awarded a Medical Device Establishment Licence and can now service the Canadian market through licenced healthcare professionals.

"At Cyrex, we offer clinical immunology lab testing for early detection and monitoring of today's fast growing and complex autoimmune reactivity, and we have been working with Health Canada to achieve a Medical Device Establishment Licence in order to offer our proprietary, advanced technology to Canadians," said Jean Bellin, President of Cyrex Laboratories. "Just recently, Best Health Magazine in Canada reported that over two million Canadians have been diagnosed with an autoimmune disease. Our tests give patients and their physicians the facts they need to detect and monitor autoimmune reactivities and their possible triggers so they can develop the best individualised treatment plan."

Physicians and other licenced healthcare professionals, as well as patients, interested in learning more about Cyrex Laboratories are encouraged to visit www.joincyrex.com for additional information.

About Cyrex Laboratories

Cyrex Laboratories is a clinical immunology laboratory specialising in functional immunology and autoimmunity. Cyrex offers multi-tissue antibody testing for the early detection and monitoring of today's complex autoimmune conditions. Cyrex develops innovative testing arrays through continuous collaboration with leading experts in medical research and clinical practise. Cyrex technology is built on four pillars of excellence, including the antigen purification system, optimised antigen concentration, antigen-specific validation and parallel testing technology. Cyrex is based in Phoenix, Arizona, USA and is CLIA licensed in the US and holds a Medical Device Establishment Licence in Canada.